C07D 217/14
Other than aralkyl radicals
Official title: other than aralkyl radicals
C07D217/14 (Other than aralkyl radicals) appears on 534 US grants and 447 published applications in this corpus.
Search patents in C07D- Granted patents
- 534
- Published applications
- 447
- Assignees
- 311
- Inventors
- 1,847
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 9 | 0 |
| 1978 | 10 | 0 |
| 1979 | 5 | 0 |
| 1980 | 7 | 0 |
| 1981 | 6 | 0 |
| 1982 | 8 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 6 | 0 |
| 1986 | 8 | 0 |
| 1987 | 5 | 0 |
| 1988 | 9 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 4 | 0 |
| 1992 | 9 | 0 |
| 1993 | 13 | 0 |
| 1994 | 4 | 0 |
| 1995 | 8 | 0 |
| 1996 | 10 | 0 |
| 1997 | 19 | 0 |
| 1998 | 13 | 0 |
| 1999 | 11 | 0 |
| 2000 | 10 | 0 |
| 2001 | 6 | 2 |
| 2002 | 8 | 15 |
| 2003 | 9 | 20 |
| 2004 | 13 | 32 |
| 2005 | 11 | 22 |
| 2006 | 9 | 19 |
| 2007 | 14 | 17 |
| 2008 | 7 | 16 |
| 2009 | 12 | 27 |
| 2010 | 17 | 26 |
| 2011 | 15 | 13 |
| 2012 | 23 | 18 |
| 2013 | 22 | 18 |
| 2014 | 17 | 28 |
| 2015 | 29 | 16 |
| 2016 | 16 | 21 |
| 2017 | 21 | 12 |
| 2018 | 12 | 13 |
| 2019 | 14 | 18 |
| 2020 | 10 | 14 |
| 2021 | 11 | 18 |
| 2022 | 9 | 12 |
| 2023 | 3 | 15 |
| 2024 | 9 | 14 |
| 2025 | 9 | 12 |
| 2026 | 4 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N-heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists22 Sep 2026US 12,741,957 B2Takeda Pharmaceutical Company Limited
- Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof26 May 2026US 12,637,400 B2Duk San Neolux Co., Ltd.
- Inhibitors of MLH1 and/or PMS2 for cancer treatment17 Feb 2026US 12,552,758 B2NeoPhore Limited
- Thiosemicarbazone compounds and uses thereof20 Jan 2026US 12,528,774 B2The Regents of the University of California
- Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1receptor positive allosteric modulators23 Dec 2025US 12,503,442 B2Eli Lilly and Company
- Methods of producing morphinan alkaloids and derivatives27 Aug 2026US 2026/0250729 A1Antheia, Inc.
- Preparation method and application of a chiral amine compound and its salts6 Aug 2026US 2026/0226520 A1Tongli Biomedical Co., Ltd.
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
- Methods for treating cancer14 May 2026US 2026/0130925 A1Genesis Molecular AI, Inc.
- Tetrahydroisoquinolinylmethylbenzamide compounds19 Feb 2026US 2026/0049060 A1National Health Research Institutes
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis98US 5,552,412 APfizer Inc. · 1996
- Retinoid-like heterocycles74US 5,559,248 ABristol-Myers Squibb Company · 1996